| 產(chǎn)品編號(hào) | bs-2341R |
| 英文名稱(chēng) | PGF2 alpha Rabbit pAb |
| 中文名稱(chēng) | 前列腺素F2a/PGF2 α抗體 |
| 別 名 | Prostaglandin F2 alpha; PGF2 alpha; (5Z, 9α, 11α, 13E, 15S)-9, 11, 15-Trihydroxyprosta-5, 13-dienoic acid tris salt, PGF2α?Tris. |
 |
Specific References (2) | bs-2341R has been referenced in 2 publications.
[IF=3.143] Amy Tran-Guzman. et al. In vitro impact of genistein and mono(2-ethylhexyl) phthalate (MEHP) on the eicosanoid pathway in spermatogonial stem cells. Reprod Toxicol. 2022 Jan;107:150 IF ; Mouse.
[IF=3.106] Manku G et al. Cyclooxygenase 2 (COX2) Expression and prostaglandin synthesis in Neonatal Rat Testicular Germ Cells: Effects of Acetaminophen and Ibuprofen. Andrology. 2019 Nov 9. IHC-P&ICC&ICF ; Rat.
|
| 產(chǎn)品類(lèi)型 | 小分子抗體 |
| 研究領(lǐng)域 | 腫瘤 細(xì)胞生物 免疫學(xué) |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 克 隆 號(hào) | |
| 交叉反應(yīng) | (predicted: PGF2 Alpha) |
| 產(chǎn)品應(yīng)用 |
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 0.475 kDa |
| 檢測(cè)分子量 | |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated Prostaglandin F2α |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. A positive feedback loop between endometrial PG F2α and luteal oxytocin is responsible for completion of luteolysis.
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. Also stimulates contraction of smooth muscle, such as in bronchi, with possible involvement in asthma. This effect is at least partially mediated through tachykinin release. |
